Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Endocalyx in Treatment Resistent Hypertension — Stella

Home/Treatment Resistant Hypertension/Endocalyx in Treatment Resistent Hypertension

View on ClinicalTrials.gov

Recruiting

Back to Treatment Resistant Hypertension trials

Endocalyx in Treatment Resistent Hypertension

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Netherlands

Amsterdam UMC, Amsterdam, North Holland

Key details

Phase

Safety & dosing

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

Dutch Heart Foundation, Dutch Kidney Foundation

Enrollment target

~64 participants

Started

January 2025

Primary completion

December 2027

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.